Advertisement
Screener

AngioDynamics, Inc. (ANGO) Noncash or Part Noncash Acquisition, Value of Liabilities Assumed

AngioDynamics, Inc. Noncash or Part Noncash Acquisition, Value of Liabilities Assumed

AngioDynamics, Inc. (ANGO) reported Noncash or Part Noncash Acquisition, Value of Liabilities Assumed of $0 for the 12-month period ending 2021-05-31, per its 10-K filed 2021-07-27.

Discontinued › Cash Flow › Operating Activities

us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1 · last filed 2021-07-27

  • AngioDynamics, Inc. noncash or part noncash acquisition, value of liabilities assumed for the quarter ending 2020-05-31 was $0.00.
  • AngioDynamics, Inc. noncash or part noncash acquisition, value of liabilities assumed for the quarter ending 2020-02-29 was $0.00.
  • AngioDynamics, Inc. noncash or part noncash acquisition, value of liabilities assumed for the quarter ending 2019-05-31 was -$41.00K.
  • AngioDynamics, Inc. noncash or part noncash acquisition, value of liabilities assumed for the quarter ending 2019-02-28 was -$172.00K.
  • AngioDynamics, Inc. noncash or part noncash acquisition, value of liabilities assumed for fiscal 2021 was $0.00.
  • AngioDynamics, Inc. noncash or part noncash acquisition, value of liabilities assumed for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
  • AngioDynamics, Inc. noncash or part noncash acquisition, value of liabilities assumed for fiscal 2019 was $4.65M.
  • AngioDynamics, Inc. noncash or part noncash acquisition, value of liabilities assumed for fiscal 2018 was $0.00.
Period endNoncash or Part Noncash Acquisition, Value of Liabilities Assumed 3 monthNoncash or Part Noncash Acquisition, Value of Liabilities Assumed 6 monthNoncash or Part Noncash Acquisition, Value of Liabilities Assumed 6 month as first filedNoncash or Part Noncash Acquisition, Value of Liabilities Assumed 9 monthNoncash or Part Noncash Acquisition, Value of Liabilities Assumed 12 month
2021-05-31$0.00
10-K · filed 2021-07-27
2020-05-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-27
$0.00
derived: sum of 2 quarters · filed 2021-07-27
$0.00
10-K · filed 2021-07-27
2020-02-29$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-08
$0.00
10-Q · filed 2020-04-08
2019-11-30$0.00
10-Q · filed 2020-01-08
2019-05-31-$41.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-27
-$213.00K
derived: sum of 2 quarters · filed 2021-07-27
$4.65M
10-K · filed 2021-07-27
2019-02-28-$172.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-08
$4.69M
10-Q · filed 2020-04-08
2018-11-30$4.86M
10-Q · filed 2020-01-08
$4.86K
10-Q · filed 2019-01-07
2018-05-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-10
$0.00
derived: sum of 2 quarters · filed 2020-08-10
$0.00
10-K · filed 2020-08-10
2018-02-28$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-02
$0.00
10-Q · filed 2019-04-02
2017-11-30$0.00
10-Q · filed 2019-01-07
2017-05-31$0.00
10-K · filed 2019-07-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
CERUS CORP (CERS)United States$0.525B-86.40
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
NeuroPace Inc (NPCE)United States$0.480B-28.52
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
SI-BONE, Inc. (SIBN)United States$0.830B-49.82